Welcome to Markets Desk, your midday read on what's moving and why.
Spotify's board has authorized an additional one point five billion dollars in share buybacks, bringing the total repurchase program to roughly two point two billion dollars. That's a meaningful signal of management confidence — returning capital to shareholders at these levels suggests the company believes the stock is undervalued relative to its fundamentals.
Shifting to the broader market picture, Goldman Sachs is reporting that hedge funds suffered their worst underperformance against the S and P five hundred in July in more than twenty years of recorded data. That's a striking number. It suggests the rally was narrow and fast enough to punish funds running hedged or defensive positioning — the kind of move that catches sophisticated money leaning the wrong way.
And in healthcare, Abbott Laboratories has agreed to a roughly six hundred seventy million dollar settlement to resolve a portion of litigation tied to its specialty formulas for preterm infants. This closes out a meaningful chunk of legal liability that had been hanging over the stock, though the word "portion" matters here — further exposure may remain as additional cases work through the courts.
That's the tape. Markets Desk, signing off the floor.
